Concordant with previous molecular studies, major driver events in adenocarcinoma, namely EGFR activating mutations, ALK gene rearrangement and ROS1 gene rearrangement, were rarely present in pulmonary LELC, indicating that they were less important events in the pathogenesis of pulmonary LELC [6,16,17]. This evidence concerns the gene ALK and adenocarcinoma.